Intermolecular (IMI) Misses Q4 EPS by 13c

Intermolecular (NASDAQ: IMI) reported Q4 EPS of ($0.20), $0.13 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $12.6 million.

GUIDANCE:

Intermolecular sees Q1 2016 EPS of ($0.06)-($0.04), versus the consensus of ($0.08). Intermolecular sees Q1 2016 revenue of $13.7-14.2 million, versus the consensus of $13.00 million.

For earnings history and earnings-related data on Intermolecular (IMI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c